PhotoDynamic Therapy for Line Infection Prevention (PLIP): Pilot Study on Healthy Volunteers.
- Conditions
- Light; Therapy, Complications
- Interventions
- Procedure: Methylene blue and light treatment
- Registration Number
- NCT01981460
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
We are evaluating the effect of methylene blue and visible light activation on the microbiome of the skin.
- Detailed Description
Antiseptics are routinely utilized to prevent infections of vascular catheters. We are evaluating the addition of methylene blue and light activation on skin to determine whether this inexpensive and non-toxic treatment can decrease skin pathogens and prevent blood stream infections of long-term vascular catheters. This is a pilot study of normal volunteers to determine the effect on the microbiome of the addition of methylene blue and light activation on antiseptic-treated skin.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Normal individuals without skin problems
- Smokers
- Diabetics
- Atopic dermatitis
- G-6-PD deficiency
- Eczema
- Other skin conditions
- Allergies to methylene blue or chlorhexadine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Methylene blue and light treatment Methylene blue and light treatment Methylene blue and light treatment for 17 minutes are done twice over 1 week intervals.
- Primary Outcome Measures
Name Time Method Evaluation of the skin microbiome after methylene blue treatment 1 week We compared the two arms of each subject --one arm treated with chloraprep and a biopatch \[routine treatment of skin\] to the routine treatment with the addition of methylene blue spray and light activation. The microbiome of both skin areas were assessed before and after the routine treatment and the treatment with the addition of methylene blue therapy;
- Secondary Outcome Measures
Name Time Method